1. Home
  2. APGE vs CACC Comparison

APGE vs CACC Comparison

Compare APGE & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$83.66

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

HOLD

Current Price

$424.87

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
CACC
Founded
2022
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.2B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
APGE
CACC
Price
$83.66
$424.87
Analyst Decision
Strong Buy
Hold
Analyst Count
13
1
Target Price
$109.67
$470.00
AVG Volume (30 Days)
1.1M
203.4K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
83.00
EPS
N/A
36.38
Revenue
N/A
$2,317,200,000.00
Revenue This Year
N/A
$91.73
Revenue Next Year
N/A
$3.58
P/E Ratio
N/A
$11.53
Revenue Growth
N/A
7.16
52 Week Low
$26.20
$401.90
52 Week High
$85.94
$549.75

Technical Indicators

Market Signals
Indicator
APGE
CACC
Relative Strength Index (RSI) 63.82 35.48
Support Level $73.06 $406.44
Resistance Level N/A $522.77
Average True Range (ATR) 4.54 20.20
MACD 1.27 -2.97
Stochastic Oscillator 90.56 25.76

Price Performance

Historical Comparison
APGE
CACC

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

Share on Social Networks: